BAL is excited to announce that we are now fully CGMP-compliant to current pharmaceutical requirements. The first question you may be asking yourself is what does CGMP compliant mean? It means that our pharmaceutical clients can rely upon Brooks Applied Labs for our...
We are thrilled to announce that Chuck Bagi has joined Brooks Applied Labs as a Technical Sales Specialist. As a key member of our Business Development team, Chuck is responsible for identifying and capturing new opportunities to collaborate with our pharmaceutical...
When an out-of-specification (OOS) event is encountered, investigative teams often direct their initial focus on physical attributes of the production cycle. Sifting through temperature logs, calibration data, and personnel training records can only get you so far...
In order to standardize the approach for compliance analyses to support the ICH Q3D Guideline for Elemental Impurities, the U.S. Pharmacopeia (USP) generated the guidance methods USP 232 and 233. The ICH guideline applies to new finished drug products (as defined in...
BAL’s methods are predominantly based on ICP-MS technology so it should surprise no one that the Winter Conference on Plasma Spectrochemistry is one of the highlights of our year. This year’s conference takes place February 3-8 in Pau, France, and Dr. Nausheen Sadiq...
BAL's Technical Sales Manager, Jamie Fox, is headed to Las Vegas to attend the 2018 Department of Energy Analytical Services Program (DOE ASP) Workshop. This annual training workshop will be held from August 29-30 and covers the validity, reliability, and...